3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
6
Uterine Cervical Neoplasms
4
Prostatic Neoplasms
4
Glioblastoma
4
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma
3
Glioma
3
Brain Neoplasms
3
Uterine Cervical Dysplasia
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Neuroblastoma
2
Hematopoietic and Lymphatic System Neoplasm
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Squamous Cell
2
Atypical Squamous Cells of the Cervix
2
Astrocytoma
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Squamous Intraepithelial Lesions
1
Spinal Cord Neoplasms
1
Smoking Cessation
1
Smoking
1
Sexual Dysfunction, Physiological
1
Rectal Neoplasms
1
Interventions
Ibandronic Acid
8
Gemcitabine
8
Doxorubicin
6
Cyclophosphamide
6
Zoledronic Acid
5
Radiation
4
Nivolumab
4
Irinotecan
4
pembrolizumab
3
Vincristine
3
Temozolomide
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
Docetaxel
3
Cisplatin
3
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
3
regorafenib
2
pegfilgrastim
2
Tranexamic Acid
2
Trabectedin
2
Sunitinib
2
Standard of Care
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Radiosurgery
2
Proton Therapy
2
Methotrexate
2
Injections
2
Ifosfamide
2
Etoposide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Bone Neoplasms
×
Restraint, Physical
×
Clear all
NCT05051059
2026-03-16
QOLSarcoma
Universitaire Ziekenhuizen KU Leuven
Phase NA
Recruiting
60 enrolled